Pathogenic NOTCH1 variants are associated with a spectrum of CHD in humans, and Notch signaling is known to interact with other signaling pathways such as BMP and TGF-β to facilitate EndMT in the developing heart (33–38). This evidence concerns the gene NOTCH1 and coronary artery disorder.